Estrogenic effects of 17β-aminoestrogens assessed in uteri of rats and mice
- 14 March 2005
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 510 (3), 235-239
- https://doi.org/10.1016/j.ejphar.2005.01.028
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulationThe American Journal of Cardiology, 2002
- Oral Contraceptives, Hormone Replacement Therapy and ThrombosisThrombosis and Haemostasis, 2001
- ORAL CONTRACEPTIVE PILLS AND HORMONAL REPLACEMENT THERAPY AND THROMBOEMBOLIC DISEASEHematology/Oncology Clinics of North America, 2000
- In vivo estrogen bioactivities and in vitro estrogen receptor binding and transcriptional activities of anticoagulant synthetic 17β-aminoestrogensThe Journal of Steroid Biochemistry and Molecular Biology, 2000
- Estrogenic effects of the synthetic aminoestrogen 17β-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol (pentolame)Steroids, 1998
- Anticoagulant and estrogenic effects of two new 17β-aminoestrogens, butolame [17β-(4-hydroxy-1-butylamino)-1, 3,5(10)-estratrien-3-ol] and pentolame [17β-(5-hydroxy-1-pentylamino)-1, 3,5(10)-estratrien-3-ol]Steroids, 1993
- Sex hormones and coronary disease: a review of the clinical studiesSteroids, 1990
- Estrogen replacement therapy and protection from acute myocardial infarctionAmerican Journal of Obstetrics and Gynecology, 1988
- Synthesis and molecular structure of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-3-hydroxypropylamine; an amino-estrogen with prolonged anticoagulant and brief estrogenic effectsSteroids, 1985
- Menopause and Coronary Heart DiseaseAnnals of Internal Medicine, 1978